vaayaa Inclusive Education
Technical risk assessment

Biomedical Engineering and Healthcare Technology Risk Assessment: Equipment, Patient Safety and Data Controls

A worked example of how a biomedical engineering team finds, scores and controls risks from device faults, staffing gaps, infection, data privacy and system outages in patient care.

Updated November 2026 8 hazards assessed Review every 6 months Highest risk: High to Medium
See the Biomedical Engineering and Healthcare Technology course

Executive summary

This assessment shows how a biomedical engineering service can find, rate and control the risks that most affect patient safety, staff competence and the reliability of clinical systems. Eight risks were chosen because they are plausible in routine equipment support, commissioning, handover and information management. Device misconfiguration, unsafe handover and patient data exposure carry the highest inherent scores. Each risk is scored before controls and again after existing and proposed controls. Most risks fall to Medium or Low once the added controls are in place, but patient harm from equipment failure remains Medium because its impact stays serious. The first actions are a verified commissioning checklist, a competence matrix for handovers, a maintenance backlog review and tested failover for clinical records. The scores illustrate method for a student and are not a measure of any real service.

Focus area
Biomedical engineering and healthcare technology
Setting
Hospital biomedical engineering service supporting patient care equipment and clinical information systems
Method
Five by five likelihood and impact risk register with inherent and residual scoring

Scope

This assessment covers a biomedical engineering service that maintains, configures and supports patient care equipment and the clinical systems linked to it, including handovers to clinical staff. It considers risks to patients, staff, data and service continuity. Assumptions are that the setting is a general acute hospital, the jurisdiction is not specified, and the equipment mix is typical of a mid-sized site. It is an educational example and not a site-specific assessment.

Context

The service has a biomedical engineering manager, several technicians, a clinical applications analyst and an information governance lead. It keeps an asset register, schedules preventive maintenance, responds to faults raised by ward staff, and commissions new equipment with clinical teams. Patient monitoring, infusion, ventilation and imaging devices connect to shared networks and records. Each risk is scored before controls to show its natural level, then again after existing controls and the additional controls proposed here. Specialist clinical, medical device and information security review is needed for any real decision.

Objectives, assets and stakeholders

The objective is to keep patients safe when equipment is installed, configured, maintained and retired, to protect staff and patient information, and to keep clinical services running when systems fail. The assets in scope are patient care devices, their configuration and calibration records, the asset register, clinical information systems, spare parts and the competence of the technical team. Stakeholders include patients and their families, nursing and medical staff, the biomedical engineering team, information governance staff, suppliers and maintenance contractors, hospital leadership and the regulators who oversee healthcare services. Each risk has one owner role. The biomedical engineering manager keeps the register current and reports to the clinical governance committee each quarter.

Risk matrix: before and after controls

Each cell shows hazard numbers placed by likelihood and impact. Compare the two grids to see how controls move each hazard.

Before controls

Inherent risk

Risk before controls: rows are likelihood from almost certain to rare, columns are impact from insignificant to catastrophic. Cells list hazard numbers.
1
Insignificant		 2
Minor		 3
Moderate		 4
Major		 5
Catastrophic
5 Almost certain
4 Likely Likelihood 4, impact 2, score 8, medium: H08 Likelihood 4, impact 3, score 12, high: H02 Likelihood 4, impact 4, score 16, high: H05
3 Possible Likelihood 3, impact 3, score 9, medium: H07 Likelihood 3, impact 4, score 12, high: H04 H06 Likelihood 3, impact 5, score 15, high: H01 H03
2 Unlikely
1 Rare

After controls

Residual risk

Risk after controls: rows are likelihood from almost certain to rare, columns are impact from insignificant to catastrophic. Cells list hazard numbers.
1
Insignificant		 2
Minor		 3
Moderate		 4
Major		 5
Catastrophic
5 Almost certain
4 Likely
3 Possible
2 Unlikely Likelihood 2, impact 2, score 4, low: H07 H08 Likelihood 2, impact 3, score 6, medium: H02 H04 H06 Likelihood 2, impact 4, score 8, medium: H01 H03 H05
1 Rare
  • Low 1 to 4
  • Medium 5 to 9
  • High 10 to 16
  • Critical 17 to 25

Hazard register

A summary first, then the detail for each hazard.

Summary of hazards with scores before and after controls
No.HazardBeforeAfterOwner
H01 Incorrect configuration or calibration of patient equipment 15 High 8 Medium Biomedical engineering manager
H02 Competence gaps and unsafe handover between technicians and clinical staff 12 High 6 Medium Clinical applications analyst
H03 Equipment failure during patient use 15 High 8 Medium Senior technician
H04 Infection and exposure from reusable equipment 12 High 6 Medium Infection prevention and control lead
H05 Patient data exposure and consent documentation gaps 16 High 8 Medium Information governance lead
H06 Clinical information system outage affecting monitoring or records 12 High 6 Medium Head of digital services
H07 Unapproved configuration change or software update bypassing change control 9 Medium 4 Low Biomedical engineering manager
H08 Supplier failure, late parts or weak service agreement 8 Medium 4 Low Procurement and contracts manager
H01

Incorrect configuration or calibration of patient equipment

Safety Before 15 After 8

A device is set up with wrong alarm limits, unit settings, calibration values or accessory profiles, so readings or delivered doses are inaccurate when it is used on a patient.

Who or what is affected: Patients, nursing and medical staff, biomedical engineering team

Causes

Rushed commissioning, manual entry of settings and profiles copied from earlier devices.

Consequences

Inaccurate treatment, delayed recognition of deterioration, patient harm and regulatory scrutiny.

Existing controls

  • Devices are checked against a commissioning form before first use.
  • Calibration is recorded in the asset register after each service.

Control gaps

The check is often done by one person, and settings are not compared with the clinical order.

Additional controls

  • Prevent: Require a two person verified configuration check with recorded settings before any device enters clinical use.
  • Detect: Audit a sample of configured devices each month against the commissioning record.
Likelihood 3 x impact 5 before; 2 x 4 after Owner: Biomedical engineering manager Target: Within 30 days Early warning: Configuration changes recorded without a completed verification check.
H02

Competence gaps and unsafe handover between technicians and clinical staff

People Before 12 After 6

Technicians or receiving staff lack current training for a device class, or a handover omits open faults, loan status or safety warnings, so the next person makes an unsafe decision.

Who or what is affected: Patients, technicians and clinical staff receiving equipment

Causes

Staff turnover, agency cover and training records kept in several places.

Consequences

Device misuse, missed faults, delayed care and a poor safety record.

Existing controls

  • Technicians hold a training record kept by the department.
  • Handover notes are written at the end of each shift.

Control gaps

Competence records are not checked against the device list, and handover forms vary by team.

Additional controls

  • Prevent: Restrict high risk device tasks to staff whose competence is confirmed in a current matrix.
  • Respond: Pause the task and call the senior technician when a handover item is unclear.
Likelihood 4 x impact 3 before; 2 x 3 after Owner: Clinical applications analyst Target: Within 45 days Early warning: A handover where the receiver has not confirmed competence for the device.
H03

Equipment failure during patient use

Safety Before 15 After 8

A ventilator, infusion pump, monitor or defibrillator fails or behaves unexpectedly because preventive maintenance is overdue, a part wears out or a battery is not replaced.

Who or what is affected: Patients, bedside nurses and clinical teams

Causes

Long repair queues, missing spare parts and maintenance deferred to save time.

Consequences

Interrupted treatment, delayed care, patient harm and a serious incident review.

Existing controls

  • Critical devices have a planned preventive maintenance schedule.
  • Ward staff report faults through a logged request route.

Control gaps

Overdue lists are reviewed weekly, not daily, and the loan pool is not tested.

Additional controls

  • Prevent: Replace batteries and high wear parts on a fixed interval set by manufacturer guidance.
  • Detect: Run a daily check of the list of devices overdue for service.
  • Recover: Keep a loan pool of tested backup devices for each critical class.
Likelihood 3 x impact 5 before; 2 x 4 after Owner: Senior technician Target: Within 60 days Early warning: Critical devices with preventive maintenance overdue beyond the agreed interval.
H04

Infection and exposure from reusable equipment

Safety Before 12 After 6

Reusable devices, accessories or sensors are not cleaned, disinfected or stored correctly between patients, so pathogens or body fluids spread to patients and staff.

Who or what is affected: Patients, cleaning and clinical staff, technicians repairing devices

Causes

Heavy workloads, unclear cleaning responsibility and accessories shared between wards.

Consequences

Healthcare associated infection, exposure incidents, outbreak investigation and staff absence.

Existing controls

  • Cleaning instructions are displayed on each device class.
  • Repairs of soiled devices are logged before work starts.

Control gaps

Repair teams do not always check decontamination status before opening a device.

Additional controls

  • Prevent: Tag each reusable item with a clean or used status and store clean items sealed.
  • Detect: Check a sample of returned devices for residue at each service visit.
Likelihood 3 x impact 4 before; 2 x 3 after Owner: Infection prevention and control lead Target: Within 30 days Early warning: A device returned for repair without a completed decontamination label.
H05

Patient data exposure and consent documentation gaps

Technology and data Before 16 After 8

Clinical records, device logs or images are viewed or shared without need, or are kept without a clear record of consent and purpose, so personal information reaches people who should not see it.

Who or what is affected: Patients, staff and families whose information is held

Causes

Shared logins, screenshots sent to personal devices and unclear consent records for research or teaching use.

Consequences

Privacy breach, loss of patient trust, enforcement action and distress to patients.

Existing controls

  • Access to the clinical system needs a named login and a role.
  • Staff sign a confidentiality agreement when they join.

Control gaps

Logs are reviewed only after a complaint, and consent for reuse of device data is not recorded consistently.

Additional controls

  • Prevent: Limit access to device logs and images to the roles that need them and remove unused accounts each quarter.
  • Detect: Review access logs for unusual viewing of records and follow up each alert.
  • Respond: Report suspected exposure to the privacy officer at once and contain any copies.
Likelihood 4 x impact 4 before; 2 x 4 after Owner: Information governance lead Target: Within 30 days Early warning: Repeated viewing of one record by a user with no assigned patient.
H06

Clinical information system outage affecting monitoring or records

Technology and data Before 12 After 6

A network fault, failed server or software error stops device data feeds or the electronic record, so clinical staff lose access to readings, orders and history during care.

Who or what is affected: Patients, clinical teams and digital services staff

Causes

Single points of failure in the network, ageing servers and unplanned software updates.

Consequences

Delayed treatment, duplicated orders, missed alarms and a serious incident.

Existing controls

  • Backups of the clinical record run every night.
  • Ward staff keep paper downtime forms in each area.

Control gaps

Restore tests use a sample file rather than the full record, and paper forms are often out of date.

Additional controls

  • Recover: Test a full restore of the clinical record and device data feed each quarter and record the time taken.
  • Respond: Switch critical monitors to stand alone mode when the network drops and inform the on call engineer.
Likelihood 3 x impact 4 before; 2 x 3 after Owner: Head of digital services Target: Within 60 days Early warning: Device data feed interrupted for longer than the agreed recovery time.
H07

Unapproved configuration change or software update bypassing change control

Legal and compliance Before 9 After 4

Engineers or vendors change device software, settings or network connections without approval or testing, so a device no longer matches the cleared version or the clinical requirement.

Who or what is affected: Patients, clinical teams, regulators and suppliers

Causes

Urgent fixes made under pressure and vendor remote access used without review.

Consequences

Unexpected device behavior, breach of rules that govern device use, audit findings and loss of supplier support.

Existing controls

  • Software updates are logged in the asset register.
  • Vendor engineers sign in through a named account.

Control gaps

Approved versions are not kept in one list, and remote sessions are not recorded.

Additional controls

  • Prevent: Require a documented change request, test and clinical sign off before any update is made.
  • Detect: Compare installed software versions with the approved list each month.
Likelihood 3 x impact 3 before; 2 x 2 after Owner: Biomedical engineering manager Target: Within 45 days Early warning: A device found running a software version not on the approved list.
H08

Supplier failure, late parts or weak service agreement

Supplier Before 8 After 4

A contractor or parts supplier fails to deliver, withdraws support for an older model or misses the agreed response time, so devices stay out of service or are repaired by people without current training.

Who or what is affected: Patients, clinical teams and biomedical engineering staff

Causes

Older models with limited support, single source parts and contracts renewed without review.

Consequences

Extended device downtime, unsafe repairs and higher costs for emergency work.

Existing controls

  • Service agreements set response times for critical devices.
  • Two suppliers are listed for common parts.

Control gaps

Response times are not measured against the contract, and end of support dates are not tracked.

Additional controls

  • Prevent: Check each agreement for response times, parts availability and end of support dates before renewal.
  • Recover: Keep a list of approved local alternatives for each critical device class.
Likelihood 4 x impact 2 before; 2 x 2 after Owner: Procurement and contracts manager Target: Within 90 days Early warning: A supplier missing agreed response times on two or more critical call outs in a quarter.

Rating method and evaluation

Each risk is rated on two five-point scales. Likelihood runs from Rare to Almost certain, and impact runs from Insignificant to Catastrophic, with harm to a patient always weighted heavily. Multiplying the two gives a score from 1 to 25, which falls into four bands: Low from 1 to 4, Medium from 5 to 9, High from 10 to 16 and Critical from 17 to 25. Inherent risk is the score before any controls, judged as if existing controls were absent. Residual risk is the score after existing controls and the additional controls proposed. Residual scores must never be higher than inherent, and where inherent is 10 or more, residual must be lower. Any Critical or High residual needs senior clinical and engineering attention and a dated plan. Medium needs routine controls with a named owner, and Low is accepted and watched. Ratings are challenged by clinical users, technicians and the information governance lead at each review, and any rating is reopened when an indicator reaches its threshold or after a reportable incident.

Likelihood, impact and rating bands

Likelihood

  • 5 Almost certain: Expected to happen in most circumstances.
  • 4 Likely: Will probably happen in many circumstances.
  • 3 Possible: Could happen at some time.
  • 2 Unlikely: Not expected, but it could happen.
  • 1 Rare: Only in exceptional circumstances.

Impact

  • 1 Insignificant: No lasting effect. Handled within routine work.
  • 2 Minor: Small effect that is quickly corrected.
  • 3 Moderate: Noticeable effect that needs managed effort to correct.
  • 4 Major: Serious effect on people, delivery or reputation.
  • 5 Catastrophic: Severe or lasting effect that threatens the whole activity.

Bands (likelihood x impact)

  • Low (1 to 4): Accept and monitor.
  • Medium (5 to 9): Manage with routine controls.
  • High (10 to 16): Senior attention and a treatment plan.
  • Critical (17 to 25): Act first. Do not proceed until reduced.

Monitoring, escalation and review

Review this assessment every 6 months, and sooner when an indicator below reaches its threshold.

Early-warning indicators and escalation thresholds
Indicator to watchEscalate when
Critical devices with preventive maintenance overdue beyond the agreed interval.Escalate to the biomedical engineering manager when any critical device is overdue, and to the clinical governance committee after 14 days.
Configuration changes recorded without a completed verification check.Escalate to the biomedical engineering manager at once, and withdraw the device from clinical use until it is verified.
Handovers where the receiving staff member has not confirmed competence.Escalate to the clinical lead for the area the same day, and pause the task until competence is confirmed.
Unauthorized access attempts or records viewed outside a clinical need.Escalate to the information governance lead within one working day, and to the privacy officer if personal data is involved.
Clinical system downtime or failed restore tests in the last quarter.Escalate to the head of digital services when downtime exceeds the agreed recovery time, and to hospital leadership if it repeats.

Contingency arrangements

If a device fails during patient use or a clinical system goes down, the biomedical engineering manager stops use of the affected equipment or service and labels it out of service. Clinical staff move patients to backup equipment, and the clinical lead confirms safe care. Affected records are restored from the latest tested backup, and paper downtime forms are used until systems return. Incidents are reported through the usual clinical governance route, and the manufacturer or supplier is contacted through the agreed service channel. Patients and families are told what they need to know early and plainly.

Prioritized action plan

  1. Introduce a verified commissioning and configuration check with sign-off, owner biomedical engineering manager, within 30 days.
  2. Build a competence matrix and structured handover form for every technician and device class, owner clinical applications analyst, within 45 days.
  3. Clear the maintenance backlog for critical devices and confirm spare parts, owner senior technician, within 60 days.
  4. Enable access controls and test failover for the clinical records system, owner information governance lead, within 30 days.

Conclusion

Safe biomedical engineering depends on steady habits: verified commissioning, current competence records, controlled handovers, maintenance on schedule, protected patient data and tested recovery. The highest scores sit with misconfiguration, unsafe handover and data exposure, and each has controls that bring the residual score down. Treat the register as a living record, review it on the stated cycle, and seek qualified clinical, engineering and legal advice for any real decision.

Assumptions and limitations

Assumptions

  • The setting is a general hospital with shared clinical networks, and the governing rules are not named because jurisdiction is unspecified.
  • Technicians hold recognized training, but competence records are kept in several places and are not fully current.
  • Equipment is maintained partly in house and partly by external suppliers under service agreements.

Limitations

  • The scores are examples for learning and do not describe any real hospital, device or patient group.
  • Clinical, device and data protection rules vary by setting and change over time, so specialist review is needed.
  • This is educational content and is not clinical, engineering or legal advice.

Related frameworks to study

  • Hazard analysis and failure mode and effects analysis
  • Hierarchy of controls
  • Three lines model of risk ownership
  • Change control and configuration management

Technical Risk Assessment

China, India, United States, Indonesia, Pakistan, Nigeria, Brazil, Bangladesh, Russia, Japan, Mexico, Philippines, Vietnam, Egypt, Turkey, Germany, United Kingdom, France, Italy, Canada, South Korea, Australia, Spain.

For Learning Reference Only: This assessment demonstrates how risk assessment principles are applied in a practical setting, providing a useful reference for learning and understanding. Actual assessments may be adapted to suit specific site conditions and circumstances.

Keep learning

Study the subject behind this assessment.

Biomedical Engineering and Healthcare Technology course Read the best practices for this course

More Technical risk assessments

Hourly Active: 39,047 Learners